Metabolic Reprogramming in Retinoblastoma Patients: Treatment Naïve Active Retinoblastoma Versus Regressed Tumors Post-Treatment
The serum metabolic profile changes based on tumor status (active versus regressed). Serum metabolites may serve as a prognostic biomarker suggestive of tumor activity and response to treatment.
Authors
- Krishna Mohan Poluri (ORCID: https://orcid.org/0000-0003-3801-7134)
- Khushboo Gulati (ORCID: https://orcid.org/0000-0001-5290-8983)
- Manikyaprabhu Kairamkonda (ORCID: https://orcid.org/0000-0001-7935-6859)
- Shivani Malpotra (ORCID: https://orcid.org/0000-0003-3524-4219)
- Swathi Kaliki (ORCID: https://orcid.org/0000-0002-0800-9961)
- Harshi Saxena
- Radhika Manukonda
Institutions
- Indian Institute of Technology Roorkee (IN)
- L V Prasad Eye Institute (IN)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1167/iovs.66.15.12
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00